TLR4 is upregulated in HBV-related hepatoma cells, and promotes their growth, while inhibiting the apoptosis of these cells, by activating the extracellular signal-regulated kinase (ERK)-1/2 signaling pathway (29). Here, MAPK3 is linked to hepatocellular carcinoma.